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demonstrates an analgesic effect as good as diamorphine and
bupivacaine. Not surprisingly, the intra-articular injection of opiate
was associated with a signiﬁcant incidence of post operative
nausea and vomiting.
The limitation in the study was the small number of patients and
a larger group may well have shown statistical signiﬁcance in
time to discharge. If this were the case the difference in price of
bupivacaine and diamorphine (£3.78) compared to Viscoseal®
(£52.88) is small compared to the cost of an overnight stay
(£180-NHS & £400-PS). Viscoseal® was well tolerated and safe
and no adverse reactions occurred during the study.
We do recommend the use of Viscoseal® as an analgesic intra-
articular injection following arthroscopic shoulder surgery.
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PATIENTS’ PERCEPTIONS OF THE EFFECT OF
HYALURONIC ACID (EUFLEXXA) ON KNEE PAIN
INDUCED DIFFICULTIES WITH ACTIVITIES OF DAILY
LIVING AND SOCIAL OR LEISURE ACTIVITIES
E. Onel1, D.L. Kerney2, M.R. Rogers3
1Ferring Pharmaceuticals, Parsippany, NJ; 2InfoMedics, Inc.,
Woburn, MA; 3West Houston Orthopedic and Sports Medicine
Center, Houston, UT
Purpose: To ascertain patients’ perceptions of the level of re-
lief obtained with Euﬂexxa (hyaluronic acid) for pain due to
osteoarthritis in the knee as it pertains to their activities of
daily living (ADLs) and their leisure or social activities after 3
months and after 6 months, and to report that information back
to physicians. The ability of patients to take care of themselves
is reﬂected in their ADLs; depression is related to social and
leisure activities.
Methods: 1,261 US physicians participated in this ongoing
prospective study by identifying patients eligible for treatment
with Euﬂexxa and providing them with survey materials. Patients
wishing to participate voluntarily telephoned a study coordina-
tor, provided consent, and used an automated interactive voice
response system to complete surveys about their condition at
baseline (before treatment with Euﬂexxa), after three months,
and after six months; of 518 patients enrolled, 161 (31%) com-
pleted all three surveys (mean age 65; 67% female). The survey
content included questions on patient ADLs and social or leisure
activities, as well as demographic information and other clinical
questions. After a patient completed each follow-up survey, the
physician received a one-page summary.
Results: Patients receiving Euﬂexxa reported a decrease in the
amount that their knee pain interfered with their ADLs, with a
mean baseline score of 5.8 (range of 0=doesn’t interfere at all
to 10=interferes very much) decreasing to 3.7 at 3 months and
maintaining at 3.9 at 6 months. Patients receiving Euﬂexxa also
reported a decrease in the amount that their knee pain interfered
with their social and leisure activities, with a mean baseline
score of 5.6 (range of 0 to 10) decreasing to 3.6 at 3 months and
maintaining at 3.7 at 6 months.
Conclusions: Based on patients’ perceptions, Euﬂexxa is effec-
tive for reducing the amount that knee pain interferes with their
ADLs, allowing this population to better care for itself even as
it ages. Euﬂexxa is also effective at reducing the amount that
knee pain interferes with social and leisure activities, allowing
this population greater interactions and potentially decreasing
the risk for depression. Through surveys such as this, patients
can communicate to physicians their impressions of the impact
of the medication on their condition. Physicians can then view
this subjective information in conjunction with objective, clinical
evaluations in an effort to optimize a patient’s treatment and
achieve the best possible outcome.
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A STANDARDISED HERBAL REMEDY MADE FROM
ROSA CANINA REDUCES PAIN IN PATIENTS SUFFERING
FROM OSTEOARTHRITIS
K. Winther1, A. Kharazmi2
1Frederiksberg Hospital, University of Copenhagen,
Copenhagen, Denmark; 2Rigshospitalet, University of
Copenhagen, Copenhagen, Denmark
Purpose: In clinical trials on osteoarthritis, i-ﬂex™/LitoZin™,
a standardised rose hip powder produced by HybenVital, has
shown anti-inﬂammatory and cell preserving capacity and a re-
duction in symptom score using WOMAC. This study aimed to
investigate if a change in symptom score (primary effect variable:
pain) could be detected using daily evaluation.
Methods: This randomized, double-blind, cross-over study in-
cluded patients with at least light to moderate pain from os-
teoarthritis. The patients were treated with either placebo or rose
hip powder (5g daily) for a period of 3 months, after which the
placebo group was changed to active treatment and vice versa.
On inclusion and after 3 months of each treatment period pain
was estimated on a 10 step categorical scale (10 indicating the
worst pain experienced). Additionally, on a daily basis throughout
the whole 6 months study period the following parameters were
evaluated: pain, stiffness, general wellbeing, quality of sleep and
mood, using similar scales as for pain.
Results: Categorical pain scales were available from 67 patients
and daily evaluation from 47 patients. In the former group of
67 patients, active treatment tended to be superior to placebo
although not signiﬁcantly (p<0.067). As a strong carry-over ef-
fect was detected, a Mann-Whitney test comparing the two
groups after only 3 months treatment was applied. This analysis
demonstrated signiﬁcant effects of active treatment (p<0.042).
Pain, when evaluated on the day by day basis in all the avail-
able patients, was in favour of active treatment (p<0.020). A
Mann-Whitney test applied after 3 months treatment supported
these ﬁndings (p<0.036). An identical pattern was observed for
stiffness, wellbeing, sleeping quality and mood, which all signiﬁ-
cantly improved as a result of active therapy, irrespective of the
statistical methodology used.
Conclusions: These data suggest that the present rose hip
powder reduces symptoms of osteoarthritis and that a daily eval-
uation of symptom score can result in a more detailed evaluation,
especially regarding the onset and time course of symptom relief.
Pain: Pathophysiology
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ANALGESIC EFFECT OF NEUROTROPIN ON CHRONIC
PAIN OF MONO-IODOACETATE-INDUCED
OSTEOARTHRITIS RATS
M. Naiki, T. Numazawa, K. Sawada, T. Okada, N. Taguchi,
H. Namba, M. Kawamura
Department of Development Research, Instutute of Bio-Active
Science, Nippon Zoki Pharmaceutical CO., LTD., Hyogo, Japan
Purpose: Neurotropin is a non-protein extract from the inﬂamed
skin of rabbits inoculated with vaccinia virus and has been
widely used to treat chronic pain of diseases such as lumbago,
neck-shoulder-arm syndrome, osteoarthritis (OA), post-herpetic
neuralgia (PHN),and subacute myelo-optico-neuropathy (SMON)
in Japan. In this study, the analgesic effect of Neurotropin was
compared with NSAIDs using mono-iodoacetate (MIA)-induced
OA model, and the action mechanism of analgesic effect of
Neurotropin was examined.
C212 Poster Presentations
Methods: Experimental OA was induced by intra-articular injec-
tion of MIA into right hind knee of male Wistar rats. Mechanical
hyperalgesia and knee joint pain were measured by von Frey ﬁla-
ment and Incapacitance Tester, respectively. First, we examined
the dose- and the time-dependency of analgesic effect of single
administration of Neurotropin on the pain of MIA-induced OA
rats. To clarify the effects of repetitive dosing on OA pain, Neu-
rotropin at doses of 100 or 200 NU/kg was orally administered to
MIA-induced OA rats from day 7 to day 28. Furthermore, repet-
itive oral administrations of Neurotropin (200 NU/kg), loxoprofen
(2 mg/kg), or meloxicam (2 mg/kg) were carried out from day 7
to day 21, and mechanical hyperalgesia and knee joint pain were
measured at 24 hours after Neurotropin administration. To clarify
the action mechanisms of Neurotropin, antagonists for receptor
of alpha2 noradrenergic, 5-HT2A, or 5-HT3 related with descend-
ing pain inhibitory pathways were intrathecally administered at
45 minutes after Neurotropin treatment, and then mechanical
hyperalgesia was measured at 15 minutes after administration of
antagonists.
Results: MIA at doses of 0.3, 1.0, 3.0 mg/site developed me-
chanical hyperalgesia and knee joint pain in a dose dependent
manner. The single administration of Neurotropin (100, 200, 400
NU/kg) ameliorated mechanical hyperalgesia of OA rats in a dose
dependent manner. This antinociceptive effect of Neurotropin at
a dose of 200 NU/kg was reached to a peak at 1 hour and
disappeared at 24 hour after Neurotropin treatment. However,
the single dose of Neurotropin was not ameliorated knee joint
pain of OA rats. In comparison, repetitive oral administration of
Neurotropin signiﬁcantly ameliorated not only mechanical hyper-
algesia but also knee joint pain of OA rats even at 24 hour
after Neurotropin treatment. Repetitive oral administration of lox-
oprofen or meloxicam was signiﬁcantly ameliorated mechanical
hyperalgesia and knee joint pain as well as Neurotropin treat-
ment. However, repetitive treatment of loxoprofen or meloxicam
induced gastro mucosal injury, but Neurotropin did not. The
inhibitory effect of single dose of Neurotropin on mechanical
hyperalgegia of OA was blocked by intrathecal injection of 30
nmol of yohimbine (alpha2 noradrenaline receptor antagonist),
100 nmol of ketanserin (5-HT2A receptor antagonist), or 30 nmol
of MDL72222 (5-HT3 receptor antagonist).
Conclusions: These results indicate that the analgesic effect
of Neurotropin on chronic pain of MIA-induced OA rats is com-
parable to NSAIDs and Neurotropin is safer than NSAIDs. The
descending pain inhibitory pathway might be involved in the
analgesic effect of Neurotropin on mechanical hyperalgesia of
MIA-induced OA rats.
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BEHAVIOURAL ASSESSMENT OF NOCICEPTION IN
OSTEOARTHRITIC RATS
J. Ferreira-Gomes, S. Adães, J.M. Castro-Lopes
Institute of Histology and Embryology, Faculty of Medicine of
Porto and IBMC, Porto, Portugal
Purpose: Pain in osteoarthritis (OA) is exacerbated both by
movement and by weight bearing on the affected joint. To in-
vestigate the occurrence and the time-course of pain related
behaviours in an experimental model of OA, we used the knee
bend, CatWalk (CW) and pin-prick tests, as well the von Frey
and Randall-Selitto tests.
Methods: OA was induced by injection of mono-iodoacetate
(MIA), in the left knee joint of adult male Wistar rats, at doses of
2 or 3 mg/joint. Control animals received a similar injection with
saline. Paw withdrawal thresholds (PWT) to von Frey ﬁlaments
and Randall-Selitto, score of knee-bend test, hind paw-print
intensity (assessed using a CW apparatus and expressed as
total intensity of the ipsilateral paw as a percentage of the total
intensity of both hindpaws) and paw withdrawal latency (PWL)
to pin-prick test were measured before the induction of OA and
on various days for up to 31 days post-injection of MIA, on both
sides.
Results: In every time point studied, PWT values and the hind-
paw load distribution of OA rats were signiﬁcantly smaller than
those observed for the control group (P<0.01 and P<0.05,
respectively), reﬂecting a mechanical allodynia. Similarly, the
knee-bend score for the OA groups showed signiﬁcantly higher
values when compared to the control animals (P<0.05), indica-
tive of the animal’s allodynia and hyperalgesia. No signiﬁcant
difference was observed between the two OA groups in any of
these tests, as well as no signiﬁcant differences were observed
in the Randall-Selitto and pin-prick test between the OA and the
control animals.
Conclusions: We conclude that the catwalk and knee-bend test
are very useful and effective methods for evaluating movement
pain and disability induced by this experimental model of OA
in the rat, and are better predictors of the animal allodynia and
hyperalgesia than the Randall-Selitto and pin-prick tests.
Supported by POCTI/SAU-NEU/60853/2004, FCT, Portugal and
FEDER.
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MITOCHONDRIAL PROTEIN ALTERATIONS IN HUMAN
ARTICULAR CHONDROCYTES REVEALED BY A
PROTEOMIC APPROACH
C. Ruiz-Romero, V. Carreira, S. Remeseiro, V. Calamia,
J. Mateos, M. Fernández, F. Galdo, F.J. Blanco
Osteoarticular and Aging Research Lab, Proteomics Unit.
Biomedical Research Center, CH Universitario Juan Canalejo.,
Coruña, Spain
Purpose: Mitochondria are involved in many cellular processes,
and mitochondrial dysfunctions have been associated with apop-
tosis, aging and a number of pathological conditions, including
osteoarthritis (OA). Mitochondrial proteins are an attractive tar-
get to study the metabolism of chondrocyte and its role in the
cartilage degradation. Using a proteomic approach, we have an-
alyzed the mitochondrial protein changes that are characteristic
of OA chondrocytes, and we have identiﬁed by these means new
OA-related mitochondrial proteins.
Methods: Chondrocytes were obtained from 6 OA patients un-
dergoing joint replacement, and from 6 cartilages from autopsies
without history of joint disease. Mitochondria were isolated by
homogenization and differential centrifugation processes. Differ-
ential expression analysis was carried out using the differential
in-gel electrophoresis technology (DIGE). Brieﬂy, mitochondrial
proteins from control and OA samples were labelled with differ-
ent ﬂuorescent dyes, mixed by pairs and co-resolved by two-
dimensional gel electrophoresis using a pool of all samples as
internal standard. Gel images were acquired with the Typhoon
scanner, and biological variation analysis was performed using
the DeCyder 6.5 software. OA-related proteins were identiﬁed by
matrix-assisted laser desorption/ionization-time of ﬂight (MALDI-
TOF) or MALDI-TOF/TOF mass spectrometry. Extended statistic
and clustering analysis of the data was performed with the EDA
module of DeCyder software. Validation of the results was carried
out by Western blotting and immunoﬂuorescence analyses.
Results: We examined more than 1500 protein spots that were
present in the six different DIGE gels. Both qualitative and quan-
titative changes in protein expression patterns between normal
and OA chondrocyte mitochondria were studied. 36 protein spots
were found to be statistically increased in OA cells compared to
